You are here

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Jacksonville, Florida, 32209 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
HIV Infection
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- HIV infection

- Second trimester of pregnancy

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Major current or prior history of obstetrical complications

- Serious current medical diseases

- Evidence of HIV virus resistance to antiretroviral agents

NCT00246610
Pfizer
Completed
Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now